Expertise in
26
conditions

Wojciech Wojakowski

Poniatowskiego 15 Street, 
Katowice, SL, PL 
Expertise in
26
conditions
Poniatowskiego 15 Street, 
Katowice, SL, PL 

Overview

Wojciech Wojakowski practices practicing medicine in Katowice, Poland.

Mr. Wojakowski is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Heart Attack, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Angioplasty.

He is actively involved in clinical research, co-authoring 425 peer reviewed articles and participating in 9 clinical trials.

Gender

Male

Locations

Poniatowskiego 15 Street, Katowice, SL 40055, Poland
Other Locations
45/47 Ziolowa St, Katowice, SL 40635, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

RELIEVE-HF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure
RELIEVE-HF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2025
Intervention Type: Other, Device
Study Phase: Not Applicable
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Drug
Study Drugs: Cardiovascular Polypill, Treatment Prevention for Secondary CV
Study Phase: Phase 3
Levosimendan In Ambulatory Heart Failure Patients
Levosimendan In Ambulatory Heart Failure Patients
Enrollment Status: Terminated
Publish Date: May 09, 2025
Intervention Type: Drug, Other
Study Drug: Levosimendan
Study Phase: Phase 4
Evaluation of Diagnostic Accuracy, Safety, and Cost-Effectiveness of the Non-Invasive Cardiolens FFR-CT Pro Method to Measure the Fractional Flow Reserve in Diagnostics of Chronic Coronary Syndromes Versus the Standard Diagnostic Modalities. A Multicentre Post-marketing Trial of a Class 2a Medical Device, Cardiolens FFR-CT Pro - Software for Non-invasive Determination of Haemodynamic Parameters in Coronary Arteries.
Evaluation of Diagnostic Accuracy, Safety, and Cost-Effectiveness of the Non-Invasive Cardiolens FFR-CT Pro Method to Measure the Fractional Flow Reserve in Diagnostics of Chronic Coronary Syndromes Versus the Standard Diagnostic Modalities. A Multicentre Post-marketing Trial of a Class 2a Medical Device, Cardiolens FFR-CT Pro - Software for Non-invasive Determination of Haemodynamic Parameters in Coronary Arteries.
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Procedure, Device
Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: (AVATAR Trial): A Multicentre Randomized Controlled Trial
Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: (AVATAR Trial): A Multicentre Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: January 12, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Enrollment Status: Completed
Publish Date: October 04, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
Enrollment Status: Completed
Publish Date: May 27, 2021
Intervention Type: Drug
Study Phase: Phase 2
Regeneration of Ischemic Damages in Cardiovascular System Using Wharton's Jelly as an Unlimited Source of Mesenchymal Stem Cells for Regenerative Medicine. Project of the National Centre for Research and Development (Poland) 'STRATEGMED II'. Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)
Regeneration of Ischemic Damages in Cardiovascular System Using Wharton's Jelly as an Unlimited Source of Mesenchymal Stem Cells for Regenerative Medicine. Project of the National Centre for Research and Development (Poland) 'STRATEGMED II'. Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)
Enrollment Status: Completed
Publish Date: April 09, 2021
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Randomized,Prospective,Double-blind Study to Evaluate Intracardiac Injections of Bone Marrow,Autologous CD133+Cells(Electromechanical Mapping Based)in Patients With Resistant Angina and no Effective Revascularization Option. RegentVsel
A Randomized,Prospective,Double-blind Study to Evaluate Intracardiac Injections of Bone Marrow,Autologous CD133+Cells(Electromechanical Mapping Based)in Patients With Resistant Angina and no Effective Revascularization Option. RegentVsel
Enrollment Status: Completed
Publish Date: September 28, 2017
Intervention Type: Biological
Study Phase: Phase 2
View 8 Less Clinical Trials

425 Total Publications

Surgical Ablation for Atrial Fibrillation During Minimally Invasive Mitral Valve Surgery: Risk Dependencies and Long-Term Survival.
Surgical Ablation for Atrial Fibrillation During Minimally Invasive Mitral Valve Surgery: Risk Dependencies and Long-Term Survival.
Journal: Innovations (Philadelphia, Pa.)
Published: September 07, 2026

Frequently Asked Questions about Wojciech Wojakowski

Is Wojciech Wojakowski a top-rated expert for Percutaneous Coronary Intervention (PCI)?

MediFind is an objective health platform that identifies experts based on real-world data. Wojciech Wojakowski is classified as an Distinguished expert for Percutaneous Coronary Intervention (PCI), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Wojciech Wojakowski participate in research or clinical trials?

Yes. Wojciech Wojakowski has published 425 articles and abstracts on conditions like Percutaneous Coronary Intervention (PCI). You can view a list of Wojciech Wojakowski's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wojakowski's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 19 Advanced Conditions
    View All 39 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile